Co-Existing Subaortic Stenosis in a Patient With Hypertrophic Obstructive Cardiomyopathy: A Rare and Interesting

Raja S Mushtaque1, Rabia Mushtaque1, Shahbano Baloch2

  • 1Cardiology, National Institute of Cardiovascular Diseases, Karachi, PAK.

Cureus
|January 8, 2021
PubMed

Insights

Hypertrophic cardiomyopathy (HCM) can cause left ventricular outflow tract obstruction. A rare co-occurrence with a subaortic membrane presents diagnostic challenges and risks heart failure.

Area of Science:

  • Cardiology
  • Genetics
  • Medical Imaging

Background:

  • Hypertrophic cardiomyopathy (HCM) is an inherited condition causing left ventricular outflow tract (LVOT) obstruction, potentially leading to symptoms like chest pain, syncope, or sudden cardiac death.
  • Diagnostic tools for HCM include echocardiography, cardiac CT, and cardiac MRI, aiding in identifying characteristic left ventricular hypertrophy.

Observation:

  • This case report details a young female with diagnosed HCM presenting with palpitations, chest pain, and shortness of breath.
  • Echocardiography revealed severe asymmetric LV hypertrophy, normal LV function, systolic anterior motion of the mitral valve, and a subvalvular aortic membrane.
  • Cardiac CT confirmed severe asymmetric septal hypertrophy, a thickened aortic valve without stenosis, and a concentric subaortic membrane.

Findings:

  • The co-existence of hypertrophic cardiomyopathy and a subaortic membrane is an uncommon finding.
  • This combination poses diagnostic difficulties and can exacerbate LVOT obstruction.

Implications:

  • Untreated cases of HCM with subaortic membranes are prone to progressive heart failure and worsening symptoms.
  • Comprehensive evaluation and meticulous surgical planning are crucial for successful intervention in such complex cases.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
153
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
126
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
157
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
129
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
244
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
207